Gradual weight reduction: Data from the phase 2 randomised controlled trial (Jastreboff et al., New England Journal of Medicine , 2023) showed meaningful reductions in body weight beginning within the first four to eight weeks of treatment, in line with the trial's dose-escalation protocol
Related Articles Novo Nordisk must face part of a securities fraud lawsuit accusing the drugmaker of misleading investors about dosing and tolerability in a late-stage clinical trial for CagriSema, after a federal judge allowed a narrower set of shareholder claims to move forward.U.S
Split dosing may help if: single morning dose produces effects that fade by afternoon, you are using higher doses (450-500mcg) where sustained levels may help, or evening administration fits your schedule better than early morning
2.4% placebo GI side-effect risk / Elevated transiently during the switch
Welcome to Cost Plus Cure, where quality meets affordability, and excellence knows no bounds.
Your health and well-being come first